No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 6.030
- -0.110-1.79%
Close May 17 16:00 ET
- 6.140
- +0.110+1.82%
Post 18:31 ET
64.88MMarket Cap-3722P/E (TTM)
6.330High5.900Low44.06KVolume6.110Open6.140Pre Close269.29KTurnover0.56%Turnover RatioLossP/E (Static)10.76MShares11.99052wk High1.81P/B47.66MFloat Cap2.38052wk Low--Dividend TTM7.90MShs Float24.840Historical High--Div YieldTTM7.00%Amplitude2.380Historical Low6.112Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million. Harrow (NASDAQ
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLantern Pharma (NASDAQ:LTRN) shares rose 14.3% to $7.04 during Friday's after-market session. The company's market cap stands at $75.7 million. As per the press release, Q1 earnings came out ye
Express News | Lantern Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 GAAP EPS Results
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Lantern Pharma (LTRN) and OmniAb (OABI)
Lantern Pharma | 10-Q: Quarterly report
Express News | Lantern Pharma Q1 2024 GAAP EPS $(0.51) Misses $(0.43) Estimate
Comments
Lantern Pharma, Oregon Therapeutics Partner to Develop AI-Driven Cancer Drug Collaboration $Lantern Pharma(LTRN.US$
$Lantern Pharma(LTRN.US$
NEWS
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
NEWS
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
3
$Lantern Pharma(LTRN.US$
NEWS
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
NEWS
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
$Lantern Pharma(LTRN.US$ 👉 KOA = WARNING 👈
( HOLO - LYT - PIXY - PIK - SWIN - WORX - VINC - SMR - AVD - BMR - HEAR - GXAI - APM - RYDE - LTRN - MEDS...) IF KEEP BUYING 👉THEN THEY MUST GO DOWN (TO $1 AND DELETE = NES ) BECAUSE CHEATERS BLOCK ( SHORT = LAO ) TRAP TRADERS 👉 BUY ONLY 👉 ONE WAY TO HELL TO STEAL MONEY WITH PAPERS 😭👹😡👊👎
( HOLO - LYT - PIXY - PIK - SWIN - WORX - VINC - SMR - AVD - BMR - HEAR - GXAI - APM - RYDE - LTRN - MEDS...) IF KEEP BUYING 👉THEN THEY MUST GO DOWN (TO $1 AND DELETE = NES ) BECAUSE CHEATERS BLOCK ( SHORT = LAO ) TRAP TRADERS 👉 BUY ONLY 👉 ONE WAY TO HELL TO STEAL MONEY WITH PAPERS 😭👹😡👊👎
$Lantern Pharma(LTRN.US$ upwards correction
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg